Skip to main content

OSDH Weekly Briefing Recap

Thursday, October 07, 2021

OKLAHOMA CITY — The Oklahoma State Department of Health held a media briefing today, Oct. 7, to provide updates on the state’s response to COVID-19.

Below, please see highlights from the discussion. A recording of the briefing can be found here.

BRIEFING HIGHLIGHTS:

  • COVID-19 numbers and hospitalizations in Oklahoma continue trending down, and health officials are cautiously optimistic that this trend will continue.
    • According to today’s data, the new case 7-day average of 1,224 is 56% lower than the peak number of 2,806 reported on August 30.
    • Hospitalizations are 45% lower and occupied ICU beds are 38% lower than they were on August 30.
  • Data continues to reinforce the effectiveness of the COVID-19 vaccines at preventing cases, hospitalizations and deaths.
    • A newly released HHS report linked vaccination to the reduction of 7,500 COVID-19 cases, 2,800 hospitalizations and 1,100 deaths among seniors in Oklahoma during the first part of 2021.
    • Among nearly 1.9 million fully vaccinated residents in Oklahoma, there have only been an estimated 11,700 reported breakthrough cases of COVID-19.
  • The best thing you can do right now to protect yourself and your loved ones is to get vaccinated. As of this week:
    • 4,222,148 total doses have been administered
    • 1,904,981 Oklahomans have completed the full series; this includes:
      • 48.1% of the total population
      • 59.5% of the adult population
      • 80.4% of the 65+ population
    • 2,235,643 Oklahomans have received at least 1 dose; this includes:
      • 57.1% of the total population
      • 70.4% of the adult population
      • 92.5% of the 65+ population
    • 90,950 booster and third doses have been administered from both state and federal sources.
      • This count includes anyone who is fully vaccinated and has received another dose of COVID-19 vaccine — whether it is the third dose of Pfizer or Moderna vaccine approved for immunocompromised individuals, or the Pfizer booster dose approved for individuals 65+ or certain other adults at high risk of severe COVID-19.


###

Last Modified on Oct 11, 2021
Back to Top